U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Drugs@FDA

Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Original NDA and Original BLA Approvals
April 1968

This report includes NDAs [including NDAs for new molecular entities (NMEs)] and BLAs (including new biological products) approved for the first time during the selected month. Original BLA/NDA approvals by CBER are not included in Drugs@FDA. This report does not include approved NDA or BLA supplements, approved ANDAs, or tentatively approved ANDAs/NDAs.

Click on the Drug Name and Application Number to see information about the drug (for example, regulatory history, labeling, reviews by FDA staff).

This report was produced on August 12, 2022.

Approval Date Drug Name Active Ingredients Submission Classification * Review Priority ** Company
04/01/1968 DESFERAL
NDA #016267
DEFEROXAMINE MESYLATE Type 1 - New Molecular Entity Priority NOVARTIS
04/10/1968 PERTOFRANE
NDA #013621
DESIPRAMINE HYDROCHLORIDE Type 5 - New Formulation or New Manufacturer Standard SANOFI AVENTIS US
04/16/1968 OVRAL
NDA #016672
ETHINYL ESTRADIOL; NORGESTREL Type 1 - New Molecular Entity and Type 4 - New Combination Priority WYETH PHARMS
04/22/1968 PATHOCIL
NDA #050092
DICLOXACILLIN SODIUM WYETH AYERST
Back to Top